Top Selling Brand Adds Low GI Rating to List of Benefits
Carlsbad, Calif.,– NEXT Proteins, the leading producer of a full-line of whey protein products under the DESIGNER WHEY™ brand, has announced a low Glycemic Index first for DETOUR Whey Protein Energy Bars.
The 43 gram Caramel Peanut DETOUR Whey Protein Energy Bar has received the Low Glycemic Index Seal from Glycemic Solutions, America’s official Glycemic Index testing facility.
With a low Glycemic Index (GI) of 39, DETOUR joins a rare group of nutrition bars to be classified as low GI. These bars can help reduce sugar loads and fat cell activity in healthy Americans.
Controlling bodyfat one bite at a time.
Eating sugary carbs cranks up blood sugar level and shunts sugar into fat cells. The higher the blood sugar levels, the higher the GI of the carbohydrate you ate. Quickly absorbed and metabolized carbohydrates, like white rice (GI-98) have the highest GI scores. Slowly digested carbs like peanuts and apples have low GI scores.
Low glycemic foods like DETOUR Bars offer a variety of health benefits for those concerned about fat cell activity and fat cell growth, as well as insulin resistance.
ABOUT NEXT PROTEINS
Based in Carlsbad, Calif., NEXT Proteins was established over 15 years ago when David Jenkins combined his passion for sports and academic knowledge to create the highest quality whey protein supplements; designed to enhance the life of the consumer. From its very beginning, NEXT has been committed to excellence, delivering only the best-tasting, health-minded products in the industry. Since 1993, NEXT pioneered the development of one of the industry’s best selling proteins, DESIGNER WHEY, which powered the Company’s innovative, great tasting products such as DESIGNER WHEY Protein Powders and the first protein candy bars DETOUR and U-TURN. Under Jenkins direction, NEXT has become a leader in the protein industry, pioneering the innovation, development and manufacture of some of the most successful whey protein products in the U.S. Recognized as an authority on the many advantages of whey based products, NEXT is one of the largest contributors for furthering research on whey. The company has invested more that $7.7M dollars in whey research and clinical testing over the last 15 years. For more information visit www.nextproteins.com.